Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 10
2021 8
2022 8
2023 8
2024 7
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK study.
d'Andrea G, Miuli A, Pettorruso M, Cavallotto C, Marrangone C, Cocco A, De Filippis S, Martiadis V, Andriola I, Barlati S, Vita A, Dell'Osso BM, Sensi SL, Di Lorenzo G, Martinotti G. d'Andrea G, et al. Among authors: miuli a. J Affect Disord. 2024 Dec 15;367:583-588. doi: 10.1016/j.jad.2024.09.004. Epub 2024 Sep 2. J Affect Disord. 2024. PMID: 39233241
Misuse of Anticholinergic Medications: A Systematic Review.
Chiappini S, Mosca A, Miuli A, Semeraro FM, Mancusi G, Santovito MC, Di Carlo F, Pettorruso M, Guirguis A, Corkery JM, Martinotti G, Schifano F, Di Giannantonio M. Chiappini S, et al. Among authors: miuli a. Biomedicines. 2022 Feb 1;10(2):355. doi: 10.3390/biomedicines10020355. Biomedicines. 2022. PMID: 35203563 Free PMC article. Review.
Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial.
Ostuzzi G, Gastaldon C, Tettamanti M, Cartabia M, Monti I, Aguglia A, Aguglia E, Bartoli F, Callegari C, Canozzi A, Carbone EA, Carrà G, Caruso R, Cavallotti S, Chiappini S, Colasante F, Compri B, D'Agostino A, De Fazio P, de Filippis R, Gari M, Ielmini M, Ingrosso G, Mammarella S, Martinotti G, Rodolico A, Roncone R, Sterzi E, Tarsitani L, Tiberto E, Todini L, Amaddeo F, D'Avanzo B; VESPA Study Group; Barbato A, Barbui C. Ostuzzi G, et al. EClinicalMedicine. 2024 Feb 15;69:102491. doi: 10.1016/j.eclinm.2024.102491. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38384338 Free PMC article.
New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances.
Chiappini S, Vaccaro G, Mosca A, Miuli A, Stigliano G, Stefanelli G, Giovannetti G, Carullo R, d'Andrea G, Di Carlo F, Cavallotto C, Pettorruso M, Di Petta G, Corkery JM, Guirguis A, Stair JL, Martinotti G, Fazel S, Schifano F. Chiappini S, et al. Among authors: miuli a. Neurosci Biobehav Rev. 2024 Jul;162:105691. doi: 10.1016/j.neubiorev.2024.105691. Epub 2024 May 10. Neurosci Biobehav Rev. 2024. PMID: 38733894 Free article.
The Benzydamine Experience: A Systematic Review of Benzydamine Abuse.
Chiappini S, Miuli A, Mosca A, Pettorruso M, Guirguis A, John MC, Martinotti G, Di Giannantonio M, Schifano F. Chiappini S, et al. Among authors: miuli a. Curr Neuropharmacol. 2021 Oct 18;19(10):1728-1737. doi: 10.2174/1570159X19666210113151136. Curr Neuropharmacol. 2021. PMID: 33441070 Free PMC article.
47 results